6  April 2021

ActivCell Group AG becomes a member of the National Center of Plasma Medicine in Germany

Natrionales Zentrum für Plasmamedizin

The National Center for Plasma Medicine e.V. (NZPM) promotes research and development in the various fields of application of cold plasma therapy in Germany and beyond national borders.

With its commitment to the science-based development of this form of therapy in wound treatment as well as in other application areas, the ActivCell Group AG contributes to the spread and increasing implementation of plasma medicine as a therapeutic option in medical practice and has therefore joined the NZPM.

On March 26, 2021, ActivCell Group AG was welcomed as a member by the board of the NZPM and accepted into the association.

3  March 2021

Design protection for the devices of the ActivCell Group AG in Switzerland

Ladder to the goal

ActivCell Group AG has reached another milestone: The design of the Cellpen series has been entered in the design register by the Swiss Federal Institute for Intellectual Property.

The entry in the Designs CH register was published on February 26, 2021 with the number 145798. The inclusion in the register demonstrates that the devices of the ActivCell Group are significantly different from existing designs.

15 October 2020

CH market launch of PetCellpen® and relaunch of EquCellpen® completed

The two cold plasma therapy devices for veterinary medicine are now available through the exclusive distribution partner for Switzerland: Medical Solution GmbH in Wil SG is a renowned contact and supplier of medical technology for veterinary companies in Switzerland and Liechtenstein and is known for its good service. The ActivCell Group AG team supports Medical Solution GmbH with its expertise in providing advice and information on all aspects of plasma medicine for veterinary professionals.

25 September 2020

ActivCellpen® and EquCellpen® tested as a medical plasma source according to DIN SPEC 91315.

INP View, Foto: INP

DIN SPEC 91315 defines how the general requirements for medical plasma sources are to be tested. The ActivCellpen® and EquCellpen® have successfully passed all the prescribed chemical, physical and biological tests at the Leibniz Institute for Plasma Research and Technology e.V. (INP). The properties of the cold plasma produced were determined by the testing institute; in particular its antiseptic effect was confirmed.

14 August 2020

ActivCell AG becomes ActivCell Group AG

Various business units operate under the umbrella of the ActivCell Group, serving very different markets. It is preferable to separate the human medicine and the veterinary medicine sectors in the future due to their very different market demands and growth scenarios. Therefore, at the 5th Annual General Meeting of ActivCell AG, it was decided to change the name of the company to ActivCell Group AG. With this decision, the shareholders are supporting the Board of Directors’ progressive growth strategy.

1 August 2020

New to the team: Dr Andrea Preuss, Head of Medical Division and Member of the Executive Board

Andrea Preuss holds a doctorate in microbiology and has worked in various industry sectors during her professional career. After starting her career at Degussa as head of a microbiology laboratory, she worked for eight years in various roles at Ciba (now BASF), most recently building up the Medical Device Materials business unit there. This was followed by positions in the medical device industry, in infection control product development at B. Braun in Sempach and as Product Manager in the Medical Division of Borer Chemie in Zuchwil. For the last eight years, Dr Preuss worked at Lonza, first as Global Marketing Manager Healthcare and later as Head Global Marketing Hygiene/Disinfection. Most recently, she led a business development project there in the area of infection prevention.

29 May 2020

Competent and well-connected: the newly formed Veterinary Advisory Board

The members of ActiveCell Group AG’s Advisory Board have a broad knowledge and many years of practical experience in veterinary medicine.
With Dr Verena Denise Bracher, Dr Silvia Rüfenacht, Prof. Adrian Steiner, Dr FHV Heinz Willi Burkhardt und Dr Michael Hiestand, universities, hospitals and practices are equally represented.
Our focus areas of dermatology, bovine medicine (buiatrics), small animal and equine medicine are very well represented by the members of the Advisory Board.

9  March 2020

New to the team: Ursula Meier, Internal Sales and Admin

Ursula Meier is a qualified businesswoman with additional training in accounting and IT support. She has many years of experience in finance and controlling, IT support and administration in clinical environments. As an active horse owner, she has also attended additional training in horse husbandry, training and therapy. Ursula Meier speaks German, French, English and Italian.

1  March 2020

New CEO: Thomas Fünfschilling

Thomas Fünfschilling

Thomas Fünfschilling holds a degree in industrial engineering from the Swiss Federal Institute of Technology (ETH) and has over 15 years of experience in international marketing and sales at the management level in well-known industrial companies. He has a track record in strategy development and implementation, business development, the solutions business, project business and change management. He is the co-founder and owner of a medical technology start-up founded in 2018.

1  February 2020

New second branch in Lenzburg

Since the beginning of 2020, ActivCell AG has had a new branch at Wolfsackerstrasse 49 in Lenzburg. Workstations and meeting rooms are available there.